Jason E. Chan
Impact in
-
- COVID-19 and healthcare impacts
-
- COVID-19 Clinical Research Studies
Papers in
- Oncology 12
- CAR-T cell therapy research 5
- Cancer Cells and Metastasis 3
- Cancer Immunotherapy and Biomarkers 3
- Vascular Tumors and Angiosarcomas 2
-
- Sarcoma Diagnosis and Treatment 5
- Co-authors
- Richard D. Kolodner (3 shared papers)Huamei Zhang (1 shared paper)Philip Andrews (1 shared paper)Jingkai Yu (1 shared paper)Trey Ideker (1 shared paper)Guozhen Liu (1 shared paper)Svetlana Pacifico (1 shared paper)Victor J. DiRita (1 shared paper)
- Journals
- Journal of Clinical Oncology (7 papers)PLoS Genetics (2 papers)Annals of Oncology (2 papers)Trends in cancer (1 paper)European Journal of Cancer (1 paper)
- Partner nations
- United StatesLithuaniaSwitzerland
In The Last Decade
Jason E. Chan
19 papers receiving 541 citations
Peers
Comparison fields: 5 of 80
- Oncology 208
- Infectious Diseases 95
- Molecular Biology 268
- Cancer Research 33
- Genetics 52
Countries citing papers authored by Jason E. Chan
This map shows the geographic impact of Jason E. Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason E. Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason E. Chan more than expected).
Fields of papers citing papers by Jason E. Chan
This network shows the impact of papers produced by Jason E. Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason E. Chan. The network helps show where Jason E. Chan may publish in the future.
Co-authors
The 25 scholars most cited alongside Jason E. Chan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 175 | |
| 2 | 2020 | 173 | |
| 3 | 2011 | 59 | |
| 4 | 2022 | 38 | |
| 5 | 2024 | 29 | |
| 6 | 2012 | 23 | |
| 7 | 2012 | 15 | |
| 8 | 2021 | 9 | |
| 9 | 2023 | 6 | |
| 10 | 2022 | 5 | |
| 11 | 2024 | 4 | |
| 12 | 2023 | 3 | |
| 13 | 2024 | 2 | |
| 14 | 2022 | 2 | |
| 15 | 2025 | 1 | |
| 16 | 2024 | 1 | |
| 17 | 2023 | 1 | |
| 18 | 2022 | 1 | |
| 19 | 2018 | 1 | |
| 20 | 2026 | 0 |
About Jason E. Chan
Jason E. Chan is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Pathology and Forensic Medicine and Neurology, having authored 20 papers that have together received 548 indexed citations. Recurring topics across this work include CAR-T cell therapy research (5 papers), Sarcoma Diagnosis and Treatment (5 papers), Cancer Cells and Metastasis (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Neuroblastoma Research and Treatments (2 papers), Vascular Tumors and Angiosarcomas (2 papers), Chromosomal and Genetic Variations (2 papers) and Lymphoma Diagnosis and Treatment (2 papers). The work is most often cited by research in Oncology (208 citations), Infectious Diseases (95 citations), Molecular Biology (268 citations), Cancer Research (33 citations) and Genetics (52 citations). Jason E. Chan has collaborated with scholars based in United States, Lithuania and Switzerland. Frequent co-authors include Richard D. Kolodner, Huamei Zhang, Philip Andrews, Jingkai Yu, Trey Ideker, Guozhen Liu, Svetlana Pacifico, Victor J. DiRita, Farshad Fotouhi and Jodi R. Parrish. Their work appears in journals such as Journal of Clinical Oncology, PLoS Genetics, Annals of Oncology, Trends in cancer and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.